drugset

drugset / Trial / NCT00220428

T-Cell Vaccination in Multiple Sclerosis (MS)

NCT00220428 ↗

Phase 1/2 Unknown 20 enrolled Sheba Medical Center

RandomizedSingle-groupOpen-labelEct

Summary

The purpose of this study is to evaluate the safety of T-cell vaccination in MS patients.

Timeline

Start: 1998-07
Primary completion: —
Completion: 2007-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	T cell vaccination	Cell therapy	—	—

Indications